These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 32234429)

  • 21. Psoriasis-like inflammation leads to renal dysfunction via upregulation of NADPH oxidases and inducible nitric oxide synthase.
    Al-Harbi NO; Nadeem A; Ansari MA; Al-Harbi MM; Alotaibi MR; AlSaad AM; Ahmad SF
    Int Immunopharmacol; 2017 May; 46():1-8. PubMed ID: 28249219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dual Inhibition of PI3K/Akt and mTOR by the Dietary Antioxidant, Delphinidin, Ameliorates Psoriatic Features In Vitro and in an Imiquimod-Induced Psoriasis-Like Disease in Mice.
    Chamcheu JC; Adhami VM; Esnault S; Sechi M; Siddiqui IA; Satyshur KA; Syed DN; Dodwad SM; Chaves-Rodriquez MI; Longley BJ; Wood GS; Mukhtar H
    Antioxid Redox Signal; 2017 Jan; 26(2):49-69. PubMed ID: 27393705
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quercetin ameliorates imiquimod-induced psoriasis-like skin inflammation in mice via the NF-κB pathway.
    Chen H; Lu C; Liu H; Wang M; Zhao H; Yan Y; Han L
    Int Immunopharmacol; 2017 Jul; 48():110-117. PubMed ID: 28499194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Losartan ointment attenuates imiquimod-induced psoriasis-like inflammation.
    Shokrian Zeini M; Haddadi NS; Shayan M; Shokrian Zeini M; Kazemi K; Solaimanian S; Abdollahifar MA; Hedayatyanfard K; Dehpour AR
    Int Immunopharmacol; 2021 Nov; 100():108160. PubMed ID: 34583123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kaempferol attenuates imiquimod-induced psoriatic skin inflammation in a mouse model.
    Liu C; Liu H; Lu C; Deng J; Yan Y; Chen H; Wang Y; Liang CL; Wei J; Han L; Dai Z
    Clin Exp Immunol; 2019 Dec; 198(3):403-415. PubMed ID: 31407330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of tumor necrosis factor-like ligand 1A (TL1A) on imiquimod-induced psoriasiform skin inflammation in mice.
    Li L; Fu L; Zhou P; Lu Y; Zhang L; Wang W; Nie J; Zhang D; Liu Y; Wu B; Chen T
    Arch Dermatol Res; 2020 Sep; 312(7):481-490. PubMed ID: 31953572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ginsenoside Rg1 abolish imiquimod-induced psoriasis-like dermatitis in BALB/c mice via downregulating NF-κB signaling pathway.
    Shi Q; He Q; Chen W; Long J; Zhang B
    J Food Biochem; 2019 Nov; 43(11):e13032. PubMed ID: 31502279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amelioration of sepsis-induced acute kidney injury through inhibition of inflammatory cytokines and oxidative stress in dendritic cells and neutrophils respectively in mice: Role of spleen tyrosine kinase signaling.
    Al-Harbi NO; Nadeem A; Ahmad SF; Alanazi MM; Aldossari AA; Alasmari F
    Biochimie; 2019 Mar; 158():102-110. PubMed ID: 30599182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acetyl-11-keto-β-boswellic acid inhibits the secretion of cytokines by dendritic cells via the TLR7/8 pathway in an imiquimod-induced psoriasis mouse model and in vitro.
    Wang MX; Zhao JX; Meng YJ; Di TT; Xu XL; Xie XJ; Lin Y; Zhang L; Wang N; Li P; Wang Y
    Life Sci; 2018 Aug; 207():90-104. PubMed ID: 29859222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topical histone deacetylase inhibitor remetinostat improves IMQ-induced psoriatic dermatitis via suppressing dendritic cell maturation and keratinocyte differentiation and inflammation.
    Jin L; Jiang Q; Huang H; Zhou X
    Eur J Pharmacol; 2024 Nov; 983():177011. PubMed ID: 39304110
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular and histopathological profiling of imiquimod induced dermatosis in Swiss Wistar rats: contribution to the rat model for novel anti-psoriasis treatments.
    Smajlović A; Haverić A; Alić A; Hadžić M; Smajlović A; Mujezinović I; Lojo-Kadrić N; Ramić J; Elez-Burnjaković N; Haverić S; Pojskić L
    Mol Biol Rep; 2021 May; 48(5):4295-4303. PubMed ID: 34097205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tryptanthrin ameliorates imiquimod-induced psoriasis in mice by suppressing inflammation and oxidative stress via NF-κB/MAPK/Nrf2 pathways.
    Xiong Y; Wang J; Wang S; Li H; Zhou X
    J Nat Med; 2023 Jan; 77(1):188-201. PubMed ID: 36378401
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Yang BY; Cheng YG; Liu Y; Liu Y; Tan JY; Guan W; Guo S; Kuang HX
    Molecules; 2019 Jun; 24(11):. PubMed ID: 31181689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of Human Mesenchymal Stem Cells Transduced with Superoxide Dismutase on Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice.
    Sah SK; Park KH; Yun CO; Kang KS; Kim TY
    Antioxid Redox Signal; 2016 Feb; 24(5):233-48. PubMed ID: 26462411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thymol activates TRPM8-mediated Ca
    Wang W; Wang H; Zhao Z; Huang X; Xiong H; Mei Z
    Toxicol Appl Pharmacol; 2020 Nov; 407():115247. PubMed ID: 32971067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topical Application of BMS-509744, a Selective Inhibitor of Interleukin-2-Inducible T Cell Kinase, Ameliorates Imiquimod-Induced Skin Inflammation in Mice.
    Otake S; Otsubaki T; Uesato N; Ueda Y; Murayama T; Hayashi M
    Biol Pharm Bull; 2021 Apr; 44(4):528-534. PubMed ID: 33473072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kan-Lu-Hsiao-Tu-Tan, a traditional Chinese medicine formula, inhibits human neutrophil activation and ameliorates imiquimod-induced psoriasis-like skin inflammation.
    Chiang CC; Cheng WJ; Lin CY; Lai KH; Ju SC; Lee C; Yang SH; Hwang TL
    J Ethnopharmacol; 2020 Jan; 246():112246. PubMed ID: 31539577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Specific Activation of CB2R Ameliorates Psoriasis-Like Skin Lesions by Inhibiting Inflammation and Oxidative Stress.
    He Y; Jia H; Yang Q; Shan W; Chen X; Huang X; Liu T; Sun R
    Inflammation; 2023 Aug; 46(4):1255-1271. PubMed ID: 37000322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topical administration of reversible SAHH inhibitor ameliorates imiquimod-induced psoriasis-like skin lesions in mice via suppression of TNF-α/IFN-γ-induced inflammatory response in keratinocytes and T cell-derived IL-17.
    Lin ZM; Ma M; Li H; Qi Q; Liu YT; Yan YX; Shen YF; Yang XQ; Zhu FH; He SJ; Tang W; Zuo JP
    Pharmacol Res; 2018 Mar; 129():443-452. PubMed ID: 29155016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dynamics and Transcriptomics of Skin Dendritic Cells and Macrophages in an Imiquimod-Induced, Biphasic Mouse Model of Psoriasis.
    Terhorst D; Chelbi R; Wohn C; Malosse C; Tamoutounour S; Jorquera A; Bajenoff M; Dalod M; Malissen B; Henri S
    J Immunol; 2015 Nov; 195(10):4953-61. PubMed ID: 26466959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.